期刊文献+

大动脉粥样硬化型缺血性脑卒中患者SLCO1B1基因多态性分布——185例分析 被引量:2

Distribution of SLCO1B1 Gene Polymorphism in 185 Patients with Large Artery Atherosclerosis-Subtype Ischemic Stroke
下载PDF
导出
摘要 目的:分析大动脉粥样硬化型缺血性脑卒中(LAA-IS)患者185例中SLCO1B1基因388A>G和521T>C多态性位点的分布。方法:LAA-IS患者185例纳入研究,通过聚合酶链反应-荧光探针方法对其外周血样本中SLCO1B1基因的388G>A和521T>C位点进行检测并统计分析其基因分型分布。结果:根据SLCO1B1基因多态性分型,185例LAA-IS患者中SLCO1B1基因388A>G位点纯合野生型占8.6%,杂合突变型占40.5%,纯合突变型占50.8%;521T>C位点纯合野生型占77.8%,杂合突变型占21.0%,纯合突变型占1.1%。结论:本组185例LAA-IS患者中分布有较多的突变型SLCO1B1基因。 Objective:To analyze the distribution of the SLCO1B1 gene 388A>G and 521T>C polymorphic loci in 185 patients with large artery atherosclerosis-subtype ischemic stroke(LAA-IS).Methods:This study recruited 185 LAA-IS patients as research subjects.The 388G>A and 521T>C loci of the SLCO1B1 gene in the peripheral blood samples were detected by the polymerase chain reaction fluorescence probe method,and the distribution of their genotyping was statistically analyzed.Results:According to the polymorphism of the SLCO1B1 gene in the 185 LAA-IS patients,at the 388A>G site,homozygous wild type accounted for 8.6%,heterozygous mutant type accounted for 40.5%,and homozygous mutant type accounted for 50.8%;at the 521T>C site,homozygous wild type accounted for 77.8%,heterozygous mutant type accounted for 21.0%,and homozygous mutant type accounted for 1.1%.Conclusion:Within the 185 cases in this study,there exists a large distribution of mutant genotypes of the SLCO1B1 gene.
作者 韩瑞玲 孙思 汪明 李艳 HAN Rui-ling;SUN Si;WANG Ming;LI Yan(Department of Clinical Laboratory,Renmin Hospital ofWuhan University,Wuhan 430060,China)
出处 《神经损伤与功能重建》 2018年第12期603-605,共3页 Neural Injury and Functional Reconstruction
基金 国家自然科学基金资助项目(No.81501427) 武汉市科学技术局(应用基础研究计划)(No.2015060101010048)
关键词 大动脉粥样硬化型缺血性脑卒中 SLCO1B1基因 基因多态性 large artery atherosclerosis-subtype ischemic stroke SLCO1B1 gene gene polymorphism
  • 相关文献

参考文献6

二级参考文献66

  • 1中华医学会神经病学分会脑血管病学组急性缺血性脑卒中诊治指南撰写组.中国急性缺血性脑卒中诊治指南2010[J].中国医学前沿杂志(电子版),2010,2(4):50-59. 被引量:1843
  • 2Lonn E,Yusuf S,Arnold MJ,菅鑫妍.血管疾病中叶酸和B族维生素的使用不能降低高半胱氨酸浓度[J].中国处方药,2006,5(6):23-24. 被引量:136
  • 3Lin-yong XU,Yi-jing HE,Wei ZHANG,Sheng Deng,Qing LI,Wei-xia ZHANG,Zhao-qian LIU,Dan WANG,Yuan-fei HUANG,Hong-hao ZHOU,Zhen-qiu SUN.Organic anion transporting polypeptide-1B1 haplotypes in Chinese patients[J].Acta Pharmacologica Sinica,2007,28(10):1693-1697. 被引量:18
  • 4Thompson PD,Clarkson P,Karas RH.Statin-associated myopathy[J].JAMA,2003,289:1681-1690.
  • 5Mammen AL,Gaudet D,Brisson D,et al.Increased frequency of DRB1*11∶01 in anti-hydroxymethylglutaryl-coenzyme A reductase-associated autoimmune myopathy[J].Arthritis Care Res(Hoboken),2012,64:1233-1237.
  • 6Armour R,Zhou L.Outcomes of statin myopathy after statin withdrawal[J].J Clin Neuromuscul Dis,2013,14:103-109.
  • 7Galtier F,Mura T,Raynaud de Mauverger E,et al.Effect of a high dose of simvastatin on muscle mitochondrial metabolism and calcium signaling in healthy volunteers[J].Toxicology Appl Pharmacol,2012,263:281-286.
  • 8Sirvent P,Fabre O,Bordenave S,et al.Muscle mitochondrial metabolism and calcium signaling impairment in patients treated with statins[J].Toxicol Appl Pharmacol,2012,259:263-268.
  • 9Larsen S,Stride N,Hey-Mogensen M,et al.Simvastatin effects on skeletal muscle:relation to decreased mitochondrial function and glucose intolerance[J].J Am Coll Cardiol,2013,61:44-53.
  • 10Garrison SR,Dormuth CR,Morrow RL,et al.Nocturnal leg cramps and prescription use that precedes them:a sequence symmetry analysis[J].Arch Intern Med,2012,172:120-126.

共引文献1262

同被引文献18

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部